Acute myocardial infarction in a 24 year-old man possibly associated with sibutramine use.


Eroglu E., Gemici G., Bayrak F., Kalkan A. K., Degertekin M.

International journal of cardiology, cilt.137, sa.2, 2009 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Kısa Makale
  • Cilt numarası: 137 Sayı: 2
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1016/j.ijcard.2008.06.017
  • Dergi Adı: International journal of cardiology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: Acute myocardial infarction, Obesity, Sibutramine, Noradrenaline, ACUTE RISK-FACTORS, WEIGHT-LOSS, SAFETY, EFFICACY, TRIGGERS, OBESITY
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Sibutramine is an anti-obesity drug, which acts by inhibiting neuronal re-uptake of noradrenaline and serotonin. Although the most frequently seen effect of sibutramine on cardiovascular system is an increase in blood pressure and pulse rate, rare but severe side effects such as sibutramine-induced ventricular arrhythmias, heart failure and cardiovascular disease-related death are also reported. We describe a 24 year-old man with low atherosclerotic risk profile who had acute myocardial infarction possibly associated with sibutramine use. (C) 2008 Elsevier Ireland Ltd. All rights reserved.